|
🐜
|
Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia
8 auth.
K. Jamroziak,
W. Młynarski,
E. Balcerczak,
Magda Mistygacz,
J. Trelińska,
M. Mirowski,
...
J. Bodalski,
T. Robak
|
7 |
2004 |
7
🐜
|
|
🐢
|
The anti-asparagines antibodies correlate with l-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia
B. Zalewska-Szewczyk,
W. Andrzejewski,
W. Młynarski,
K. Jędrychowska-Dańska,
H. Witas,
J. Bodalski
|
6 |
2007 |
6
🐢
|
|
🐬
|
The cross-reactivity of anti-asparaginase antibodies against different l-asparaginase preparations
B. Zalewska-Szewczyk,
A. Gach,
K. Wyka,
J. Bodalski,
W. Młynarski
|
6 |
2009 |
6
🐬
|
|
🐬
|
Arylamine N‐acetyltransferase (NAT2) gene mutations in children with allergic diseases
E. Zielińska,
W. Niewiarowski,
J. Bodalski,
Anna Stańczyk,
W. Bolanowski,
Grzegorz Rębowski
|
5 |
1997 |
5
🐬
|
|
🐬
|
CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland.
M. Krokowski,
J. Bodalski,
A. Bratek,
P. Machejko,
S. Caillat-Zucman
|
5 |
1998 |
5
🐬
|
|
🐢
|
The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children
E. Zielińska,
W. Niewiarowski,
J. Bodalski
|
5 |
1998 |
5
🐢
|
|
🐢
|
Development of anti‐asparaginase antibodies in childhood acute lymphoblastic leukemia
B. Zalewska-Szewczyk,
W. Andrzejewski,
J. Bodalski
|
5 |
2004 |
5
🐢
|
|
🐜
|
Genotyping of the arylamine N‐acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim‐sulfamethoxazole in infants.
7 auth.
E. Zielińska,
J. Bodalski,
K. Mianowska,
W. Niewiarowski,
G. Rebowski,
J. Skrętkowicz,
...
M. Sekulska
|
4 |
1998 |
4
🐜
|
|
🐬
|
HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population.
M. Krokowski,
J. Bodalski,
A. Bratek,
C. Boitard,
S. Caillat-Zucman
|
4 |
1998 |
4
🐬
|
